Additional findings_Adult
Gene: SERPINA1
MODERATE evidence for actionability in adults by ClinGen.
Surveillance:
A respiratory functional assessment is suggested at the end of adolescence and afterwards at 2-to-3-year intervals. Respiratory monitoring should include spirometry with bronchodilator test every year, annual plethysmography and carbon monoxide diffusion capacity, and chest CT repeatedly as per medical indication.
Liver monitoring should include physical examination including focused exam for signs of liver disease, laboratory assessment and abdominal ultrasound every 6 to 12 months (or more frequently as clinically indicated). The serum liver assessment should include transaminases (AST and ALT), alkaline phosphatase, GGT, bilirubin, albumin, coagulation tests, platelets, fat soluble enzymes, and alpha-fetoprotein.
Also suggested: additional vaccinations.
Agents to avoid: tobacco smoke.
Augmentation therapy of AAT infusions also available.
Condition is under diagnosed/diagnostic delays are common.
Some uncertainty about penetrance.
Sources: Expert listCreated: 10 Apr 2025, 5:39 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
alpha 1-antitrypsin deficiency, MONDO#0013282
Gene: serpina1 has been classified as Green List (High Evidence).
Gene: serpina1 has been classified as Green List (High Evidence).
gene: SERPINA1 was added gene: SERPINA1 was added to Additional findings_Adult. Sources: Expert list Mode of inheritance for gene: SERPINA1 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: SERPINA1 were set to alpha 1-antitrypsin deficiency, MONDO#0013282 Review for gene: SERPINA1 was set to GREEN